← FDA DRUG APPROVALS

FDA ANDA · ANDA209959

ALBUTEROL SULFATE

Sponsor: CIPLA

APPLICATION
ANDA209959
TYPE
ANDA
ORIGINAL APPROVAL
2020-04-08
LATEST ACTION
2025-11-21
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
AEROSOL, METERED
MARKETING STATUS
Prescription

Products

ALBUTEROL SULFATEPrescription
ALBUTEROL SULFATE EQ 0.09MG BASE/INH · AEROSOL, METERED · INHALATION

Approval history

2025-11-21Labeling · Supplement 21 · standardAP
2021-10-28Labeling · Supplement 10 · standardAP
2020-11-04Labeling · Supplement 7 · standardAP
2020-04-08UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →